Clinical course and related costs of patients with diabetes and heart failure and/or chronic kidney disease

Aldo Maggioni; Carlo Piccinni; Silvia Calabria; Letizia Dondi; Giulia Ronconi; N. Martini

doi:10.1016/j.atherosclerosis.2020.10.850

Related publications

Article2021

Clinical course and related costs of patients with diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Aldo Maggioni, Carlo Piccinni, Silvia Calabria, Letizia Dondi, Giulia Ronconi, Natalia De Martini

Article2016

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

Gerasimos Filippatos, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo Maggioni, Piotr Ponikowski, Adriaan A. Voors, Faı̈ez Zannad, So Young Kim, Christina Nowack, Giovanni Palombo, Peter Kolkhof, Nina Kimmeskamp‐Kirschbaum, Alexander Pieper, Bertram Pitt

Article2023

The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek‐Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Professor Gregory Lip

Article2019

Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease

Kelley R. Branch, Jeffrey L. Probstfield, John W. Eikelboom, Jackie Bosch, Aldo Maggioni, Richard K. Cheng, Deepak L. Bhatt, Álvaro Avezum, Keith A.A. Fox, Stuart J. Connolly, Olga Shestakovska, Salim Yusuf

Article2018

Risk of Stroke and Bleeding in Patients with Heart Failure and Chronic Kidney Disease: A Nationwide Cohort Study

Line Melgaard, Thure Filskov Overvad, Flemming Skjøth, Jeppe Hagstrup Christensen, Torben Bjerregaard Larsen, Professor Gregory Lip